The Food and Drug Administration is investigating reports of side effects from GLP-1 drugs like Ozempic and Wegovy, including suicidal ideation and hair loss. A large new study found no link between semaglutide, the active ingredient in some GLP-1 drugs, and suicidal ideation.
Eli Lilly's new obesity medication Zepbound (tirzepatide) recently received FDA approval. Experts explain how the GLP-1 drug works and compares to similar drugs.